Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy
Abnormal structural and molecular changes in malignant tissues were thoroughly investigated and utilized to target tumor cells, hence rescuing normal healthy tissues and lowering the unwanted side effects as non-specific cytotoxicity. Various ligands for cancer cell specific markers have been uncove...
Guardado en:
Autores principales: | Layla Al-mansoori, Philip Elsinga, Sayed K. Goda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02c94a827e154a48a2cc15bc82004766 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Retargeting Lentiviruses via SpyCatcher-SpyTag Chemistry for Gene Delivery into Specific Cell Types
por: Nagarjun Kasaraneni, et al.
Publicado: (2017) -
Cancer Patient Tissueoid with Self‐Homing Nano‐Targeting of Metabolic Inhibitor
por: Hyo‐Jin Yoon, et al.
Publicado: (2021) -
Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Shengnan Bao, et al.
Publicado: (2021) -
Lymphadenopathy after the third Covid-19 vaccine
por: Can Özütemiz, et al.
Publicado: (2021) -
Screening Plasma Exosomal RNAs as Diagnostic Markers for Cervical Cancer: An Analysis of Patients Who Underwent Primary Chemoradiotherapy
por: Oyeon Cho, et al.
Publicado: (2021)